Literature DB >> 10481152

Enzymes of parasite thiol metabolism as drug targets.

R L Krauth-Siegel1, G H Coombs.   

Abstract

The potential for chemotherapeutic exploitation of thiol metabolism in parasitic protozoa is reviewed here by Luise Krauth-Siegel and Graham Coombs. The review is based largely on discussions held at a meeting of the COST B9 Action entitled 'Chemotherapy of Protozoal Infections'*. The major questions posed were: which enzymes are the best to target; what further information is required to allow their use for rational drug development; and how can this be achieved most efficiently? Not surprisingly, only partial answers could be obtained in many cases, but the interactive discussion between the multidisciplinary group of participants provided thought-provoking ideas and will help direct future research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481152     DOI: 10.1016/s0169-4758(99)01516-1

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  14 in total

Review 1.  Parasite-specific trypanothione reductase as a drug target molecule.

Authors:  R Luise Krauth-Siegel; Oliver Inhoff
Journal:  Parasitol Res       Date:  2003-04-23       Impact factor: 2.289

2.  Leishmania major protein disulfide isomerase as a drug target: enzymatic and functional characterization.

Authors:  Noureddine Ben Khalaf; Géraldine De Muylder; Hechmi Louzir; James McKerrow; Mehdi Chenik
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

3.  Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum.

Authors:  Kristen M Massimine; Michael T McIntosh; Lanxuan T Doan; Chloé E Atreya; Stephan Gromer; Worachart Sirawaraporn; David A Elliott; Keith A Joiner; R Heiner Schirmer; Karen S Anderson
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones.

Authors:  M Chen; L Zhai; S B Christensen; T G Theander; A Kharazmi
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

5.  Glutathione derivatives active against Trypanosoma brucei rhodesiense and T. brucei brucei in vitro.

Authors:  Sylvie Daunes; Claudius D'Silva
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

6.  TcGPXII, a glutathione-dependent Trypanosoma cruzi peroxidase with substrate specificity restricted to fatty acid and phospholipid hydroperoxides, is localized to the endoplasmic reticulum.

Authors:  Shane R Wilkinson; Martin C Taylor; Said Touitha; Isabel L Mauricio; David J Meyer; John M Kelly
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

7.  Redox potential regulates binding of universal minicircle sequence binding protein at the kinetoplast DNA replication origin.

Authors:  Itay Onn; Neta Milman-Shtepel; Joseph Shlomai
Journal:  Eukaryot Cell       Date:  2004-04

Review 8.  1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.

Authors:  Didier Belorgey; Don Antoine Lanfranchi; Elisabeth Davioud-Charvet
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  A proteome reference map of Trichomonas vaginalis.

Authors:  Kuo-Yang Huang; Kuen-Yi Chien; Yin-Chun Lin; Wei-Min Hsu; I-Kai Fong; Po-Jung Huang; Yuan-Ming Yueh; Richie Ruei-Chi Gan; Petrus Tang
Journal:  Parasitol Res       Date:  2008-12-05       Impact factor: 2.289

10.  Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes.

Authors:  Erika van den Bogaart; Gerard J Schoone; Paul England; Dorien Faber; Kristina M Orrling; Jean-Claude Dujardin; Shyam Sundar; Henk D F H Schallig; Emily R Adams
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.